Femme et Homme
- | Pays :
- Romania
- Slovakia
- Italy
- Les 6 autres...
- | Organes : -
- | Spécialités : -
Extrait
This open-label study is being conducted to confirm the safety, pharmacokinetic profile and efficacy of Ruconest at a dose of 50 U/kg when used for the treatment of acute angioedema attacks in patients, from 2 up to and including 13 years of age.
Critère d'inclusion
- hereditary angioedema